Skip to main content
BDX
NYSE Life Sciences

Becton Dickinson Raises Annual Profit Forecast, Beats Q2 Estimates on Strong Device Sales

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$147.98
Mkt Cap
$41.219B
52W Low
$127.536
52W High
$187.35
52W Position info
16% above low
Off High info
21% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BDX sits 16% above its 52-week low of $127.536.

Summary

Becton Dickinson (BDX) significantly raised its annual adjusted profit per share forecast to $12.52-$12.72, up from its previous range of $12.35-$12.65, driven by robust demand for its drug-delivery devices and surgical equipment. The company also reported strong second-quarter results, with adjusted EPS of $2.90 on $4.71 billion in revenue, both exceeding analyst estimates of $2.77 and $4.67 billion, respectively. Additionally, Becton Dickinson formally appointed Vitor Roque as its Executive Vice President and Chief Financial Officer. This positive financial performance and improved outlook are material for the large-cap medical technology company, signaling strong operational momentum and likely to boost investor confidence. The news also briefly referenced the earlier spin-off of its biosciences and diagnostic solutions unit in a deal with Waters Corp (WAT).

At the time of this announcement, BDX was trading at $147.98 on NYSE in the Life Sciences sector, with a market capitalization of approximately $41.2B. The 52-week trading range was $127.54 to $187.35. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Nov 05, 2026, 6:54 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $206.00
Real-time Price: $215.31 info
Change: +$9.31 (+5%) info
Market Cap: $58.671B info
BDX
Nov 05, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.07
Real-time Price: $215.31 info
Change: +$11.24 (+6%) info
Market Cap: $58.671B info
BDX
Nov 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $205.50
Real-time Price: $215.31 info
Change: +$9.81 (+5%) info
Market Cap: $58.671B info
BDX
Oct 07, 2026, 1:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $181.41
Real-time Price: $215.31 info
Change: +$33.91 (+19%) info
Market Cap: $58.671B info
BDX
Oct 07, 2026, 8:20 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $177.43
Real-time Price: $215.31 info
Change: +$37.88 (+21%) info
Market Cap: $58.671B info